Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263783
Status:
COMPLETED
Last Update Posted:
2009-01-29
First Post:
2005-12-08
Brief Title:
Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Organization Data
Organization:
MedImmune LLC
Class:
INDUSTRY
Study ID:
MI-CP065
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedImmune LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Luz Hammershaimb MD VP Clinical Dev
Old Organization:
MedImmune Inc